ELVN

Enliven Therapeutics, Inc.CIK 1672619 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

$3.43M

23 trades · 3 insiders

Net · 90d

$-3.43M

Insiders on file

AI insights for ELVN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ELVN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Hohl Benjamin	Chief Financial Officer	177	$0	$5.40M	2026-10-19
Collins Helen Louise	Chief Medical Officer	70	$0	$6.65M	2026-10-19
BALL KRISTINE M	Director	1	$0	$0	2026-10-14
Garland J. Scott	Director	5	$0	$606.7K	2026-10-01
Derynck Mika K	Director	24	$0	$19.12M	2026-08-04
Kunkel Lori Anne	Director	10	$0	$850.2K	2026-07-06
ORBIMED ADVISORS LLC	10% Owner	6	$0	$51.68M	2026-06-22
Heyman Richard A.	Director	42	$0	$1.09M	2026-02-17
Patel Anish	Chief Operating Officer	71	$0	$5.90M	2026-02-12
Lyssikatos Joseph P	Chief Scientific Officer	94	$0	$11.75M	2026-02-12
Ballal Rahul D.	Director	31	$0	$2.24M	2026-02-12
Bauer Jake	Director	7	$0	$0	2026-02-12
Gupta Rishi	Director, 10% Owner	12	$0	$22.88M	2026-02-12
Fair Richard A.	PRESIDENT AND CEO	1	$0	$0	2025-12-11
Kintz Samuel	President and CEO	84	$0	$7.44M	2025-11-17
Phillips Andrew John	Director	4	$0	$0	2025-02-06
OrbiMed Capital GP VII LLC	Director, 10% Owner	4	$0	$22.88M	2024-05-16
5AM Ventures VI, L.P.	10% Owner	2	$0	$12.29M	2024-02-14
5AM Opportunities I (GP), LLC	10% Owner	2	$0	$7.50M	2024-01-31
5AM Opportunities I, L.P.	10% Owner	2	$0	$2.96M	2023-09-26
Schwab Andrew J.	Director, 10% Owner	5	$0	$7.04M	2023-08-24
COMMODORE CAPITAL LP	10% Owner	2	$13.7K	$0	2023-02-23
OrbiMed Genesis GP LLC	10% Owner	2	$0	$0	2023-02-23
Kolchinsky Peter	Other	1	$0	$0	2023-02-23
LANE JOHN D	Director, 10% Owner	4	$0	$0	2012-10-05
Larach Mario	Chief Executive Officer	1	$0	$0	2012-05-22
BERNDT FREDERICK C	Chief Executive Officer	3	$0	$0	2012-04-09
Schloss E Jamie	Director	1	$0	$0	2012-02-10
Marquez Antonio	Director	2	$0	$0	2012-02-08

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2026-10-19	2026-10-21	6,018	—	$0	175,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-10-19	2026-10-21	6,018	$38.48	$231.5K	38,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2026-10-19	2026-10-21	6,018	$14.85	$89.4K	44,018	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-10-19	2026-10-21	5,000	—	$0	101,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-10-19	2026-10-21	5,000	$38.47	$192.3K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-10-19	2026-10-21	5,000	$2.48	$12.4K	30,000	SEC↗
BALL KRISTINE M	Director	A Award deriv	2026-10-14	2026-10-16	23,394	—	$0	23,394	SEC↗
Garland J. Scott	Director	M Exercise deriv	2026-10-01	2026-10-05	13,000	—	$0	46,372	SEC↗
Garland J. Scott	Director	S Sale	2026-10-01	2026-10-05	13,000	$46.67	$606.7K	0	SEC↗
Garland J. Scott	Director	M Exercise	2026-10-01	2026-10-05	13,000	$15.47	$201.1K	13,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-09-17	2026-09-21	5,000	—	$0	106,268	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2026-09-17	2026-09-21	3,982	—	$0	181,018	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-09-17	2026-09-21	240	$51.48	$12.4K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-09-17	2026-09-21	5,000	$2.48	$12.4K	30,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-09-17	2026-09-21	2,916	$50.03	$145.9K	27,084	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-09-17	2026-09-21	1,844	$50.71	$93.5K	25,240	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-09-17	2026-09-21	289	$51.49	$14.9K	38,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-09-17	2026-09-21	2,194	$50.72	$111.3K	38,289	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-09-17	2026-09-21	3,535	$50.03	$176.9K	40,483	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2026-09-17	2026-09-21	3,982	$14.85	$59.1K	44,018	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2026-09-17	2026-09-21	3,982	—	$0	181,018	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-09-17	2026-09-21	289	$51.49	$14.9K	38,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-09-17	2026-09-21	2,194	$50.72	$111.3K	38,289	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-09-17	2026-09-21	3,535	$50.03	$176.9K	40,483	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2026-09-17	2026-09-21	3,982	$14.85	$59.1K	44,018	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-09-17	2026-09-21	5,000	—	$0	106,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-09-17	2026-09-21	240	$51.48	$12.4K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-09-17	2026-09-21	1,844	$50.71	$93.5K	25,240	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-09-17	2026-09-21	2,916	$50.03	$145.9K	27,084	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-09-17	2026-09-21	5,000	$2.48	$12.4K	30,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-08-17	2026-08-19	5,000	—	$0	111,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-08-17	2026-08-19	1,100	$59.35	$65.3K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-08-17	2026-08-19	5,000	$2.48	$12.4K	30,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-08-17	2026-08-19	3,900	$58.37	$227.6K	26,100	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-08-17	2026-08-19	1,388	$59.35	$82.4K	40,036	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-08-17	2026-08-19	4,630	$58.35	$270.2K	41,424	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-08-17	2026-08-19	1,388	$59.35	$82.4K	40,036	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-08-17	2026-08-19	4,630	$58.35	$270.2K	41,424	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-08-17	2026-08-19	5,000	—	$0	111,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-08-17	2026-08-19	1,100	$59.35	$65.3K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-08-17	2026-08-19	3,900	$58.37	$227.6K	26,100	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-08-17	2026-08-19	5,000	$2.48	$12.4K	30,000	SEC↗
Derynck Mika K	Director	M Exercise deriv	2026-08-04	2026-08-06	20,491	—	$0	0	SEC↗
Derynck Mika K	Director	M Exercise deriv	2026-08-04	2026-08-06	23,364	—	$0	0	SEC↗
Derynck Mika K	Director	M Exercise deriv	2026-08-04	2026-08-06	87,373	—	$0	0	SEC↗
Derynck Mika K	Director	M Exercise deriv	2026-08-04	2026-08-06	27,567	—	$0	0	SEC↗
Derynck Mika K	Director	M Exercise	2026-08-04	2026-08-06	87,373	$2.48	$216.7K	87,373	SEC↗
Derynck Mika K	Director	M Exercise	2026-08-04	2026-08-06	27,567	$25.28	$696.9K	114,940	SEC↗
Derynck Mika K	Director	M Exercise	2026-08-04	2026-08-06	23,364	$14.85	$347.0K	138,304	SEC↗
Derynck Mika K	Director	M Exercise	2026-08-04	2026-08-06	20,491	$22.47	$460.4K	158,795	SEC↗
Derynck Mika K	Director	S Sale	2026-08-04	2026-08-06	158,795	$60.21	$9.56M	0	SEC↗
Derynck Mika K	Director	M Exercise deriv	2026-08-04	2026-08-06	20,491	—	$0	0	SEC↗
Derynck Mika K	Director	M Exercise deriv	2026-08-04	2026-08-06	23,364	—	$0	0	SEC↗
Derynck Mika K	Director	M Exercise deriv	2026-08-04	2026-08-06	27,567	—	$0	0	SEC↗
Derynck Mika K	Director	M Exercise deriv	2026-08-04	2026-08-06	87,373	—	$0	0	SEC↗
Derynck Mika K	Director	S Sale	2026-08-04	2026-08-06	158,795	$60.21	$9.56M	0	SEC↗
Derynck Mika K	Director	M Exercise	2026-08-04	2026-08-06	20,491	$22.47	$460.4K	158,795	SEC↗
Derynck Mika K	Director	M Exercise	2026-08-04	2026-08-06	23,364	$14.85	$347.0K	138,304	SEC↗
Derynck Mika K	Director	M Exercise	2026-08-04	2026-08-06	27,567	$25.28	$696.9K	114,940	SEC↗
Derynck Mika K	Director	M Exercise	2026-08-04	2026-08-06	87,373	$2.48	$216.7K	87,373	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-07-17	2026-07-21	5,000	—	$0	116,268	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2026-07-17	2026-07-21	1,072	—	$0	84,966	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-07-17	2026-07-21	459	$51.55	$23.7K	29,310	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-07-17	2026-07-21	231	$50.05	$11.6K	29,769	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-07-17	2026-07-21	5,000	$2.48	$12.4K	30,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-07-17	2026-07-21	63	$53.92	$3.4K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-07-17	2026-07-21	2,184	$53.42	$116.7K	25,063	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-07-17	2026-07-21	2,063	$52.39	$108.1K	27,247	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-07-17	2026-07-21	2,564	$52.32	$134.1K	48,815	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-07-17	2026-07-21	369	$51.48	$19.0K	51,379	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-07-17	2026-07-21	324	$49.97	$16.2K	51,748	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2026-07-17	2026-07-21	1,072	$2.48	$2.7K	52,072	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-07-17	2026-07-21	2,638	$53.38	$140.8K	46,177	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-07-17	2026-07-21	123	$53.87	$6.6K	46,054	SEC↗
Kunkel Lori Anne	Director	S Sale	2026-07-06	2026-07-08	4,111	$49.98	$205.5K	47,773	SEC↗
Kunkel Lori Anne	Director	S Sale	2026-07-06	2026-07-08	5,889	$50.84	$299.4K	41,884	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2026-06-22	2026-06-24	1,477	$45.00	$66.5K	219,405	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2026-06-22	2026-06-24	787,024	$45.38	$35.72M	6,601,878	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2026-06-22	2026-06-24	46,776	$45.00	$2.10M	6,555,102	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2026-06-22	2026-06-24	24,846	$45.38	$1.13M	220,882	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-06-17	2026-06-22	5,000	—	$0	121,268	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2026-06-17	2026-06-22	6,018	—	$0	86,038	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-06-17	2026-06-22	1,133	$44.74	$50.7K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-06-17	2026-06-22	2,599	$43.87	$114.0K	26,133	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-06-17	2026-06-22	1,268	$42.83	$54.3K	28,732	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-06-17	2026-06-22	5,000	$2.48	$12.4K	30,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-06-17	2026-06-22	1,379	$42.79	$59.0K	55,639	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-06-17	2026-06-22	3,401	$43.86	$149.2K	52,238	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-06-17	2026-06-22	1,238	$44.75	$55.4K	51,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2026-06-17	2026-06-22	6,018	$2.48	$14.9K	57,018	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2026-06-15	2026-06-17	272,322	$45.02	$12.26M	7,388,902	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2026-06-15	2026-06-17	9,086	$45.02	$409.1K	245,728	SEC↗
Kunkel Lori Anne	Director	S Sale	2026-06-05	2026-06-09	1,867	$35.36	$66.0K	52,238	SEC↗
Kunkel Lori Anne	Director	S Sale	2026-06-05	2026-06-09	7,779	$34.28	$266.7K	54,105	SEC↗
Kunkel Lori Anne	Director	S Sale	2026-06-05	2026-06-09	354	$35.82	$12.7K	51,884	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-05-18	2026-05-20	5,000	—	$0	126,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-05-18	2026-05-20	223	$41.21	$9.2K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-05-18	2026-05-20	5,000	$2.48	$12.4K	30,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-05-18	2026-05-20	3,475	$39.53	$137.4K	26,525	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-05-18	2026-05-20	1,302	$40.25	$52.4K	25,223	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-04-17	2026-04-21	5,000	—	$0	131,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-04-17	2026-04-21	2,419	$47.39	$114.6K	27,441	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-04-17	2026-04-21	140	$45.81	$6.4K	29,860	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-04-17	2026-04-21	2,441	$48.06	$117.3K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-04-17	2026-04-21	5,000	$2.48	$12.4K	30,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-03-25	2026-03-27	40,000	—	$0	136,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-03-25	2026-03-27	40,000	$35.10	$1.40M	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-03-25	2026-03-27	40,000	$2.48	$99.2K	65,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-03-17	2026-03-19	5,000	—	$0	176,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-03-17	2026-03-19	5,000	$2.48	$12.4K	30,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-03-17	2026-03-19	5,000	$27.76	$138.8K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-03-10	2026-03-11	10,129	—	$0	181,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-03-10	2026-03-11	10,129	$2.48	$25.1K	35,129	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-03-10	2026-03-11	10,129	$30.19	$305.8K	25,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-03-09	2026-03-11	29,871	—	$0	191,397	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-03-09	2026-03-11	29,871	$2.48	$74.1K	54,871	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-03-09	2026-03-11	29,871	$30.02	$896.7K	25,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2026-03-06	2026-03-10	10,000	$29.58	$295.8K	51,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise deriv	2026-02-17	2026-02-19	45,000	—	$0	221,268	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	M Exercise	2026-02-17	2026-02-19	45,000	$2.48	$111.6K	70,000	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	S Sale	2026-02-17	2026-02-19	45,000	$26.17	$1.18M	25,000	SEC↗
Heyman Richard A.	Director	S Sale	2026-02-17	2026-02-19	1,230	$26.18	$32.2K	22,647	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	A Award deriv	2026-02-12	2026-02-17	150,000	—	$0	150,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	A Award deriv	2026-02-12	2026-02-17	150,000	—	$0	150,000	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	A Award deriv	2026-02-12	2026-02-17	112,500	—	$0	112,500	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	A Award deriv	2026-02-12	2026-02-17	120,000	—	$0	120,000	SEC↗
Ballal Rahul D.	Director	A Award deriv	2026-02-12	2026-02-17	17,126	—	$0	17,126	SEC↗
Bauer Jake	Director	A Award deriv	2026-02-12	2026-02-17	17,126	—	$0	17,126	SEC↗
Derynck Mika K	Director	A Award deriv	2026-02-12	2026-02-17	17,126	—	$0	17,126	SEC↗
Garland J. Scott	Director	A Award deriv	2026-02-12	2026-02-17	1,427	—	$0	1,427	SEC↗
Gupta Rishi	Director	A Award deriv	2026-02-12	2026-02-17	33,989	—	$0	33,989	SEC↗
Gupta Rishi	Director	A Award deriv	2026-02-12	2026-02-17	1,580	—	$0	1,580	SEC↗
Heyman Richard A.	Director	A Award deriv	2026-02-12	2026-02-17	19,234	—	$0	19,234	SEC↗
Kunkel Lori Anne	Director	A Award deriv	2026-02-12	2026-02-17	17,126	—	$0	17,126	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	A Award	2026-02-12	2026-02-17	25,000	—	$0	25,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	A Award	2026-02-12	2026-02-17	25,000	—	$0	61,000	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	A Award	2026-02-12	2026-02-17	18,750	—	$0	18,750	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	A Award	2026-02-12	2026-02-17	20,000	—	$0	20,000	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2026-02-06	2026-02-10	5,000	$29.04	$145.2K	740,188	SEC↗
Heyman Richard A.	Director	S Sale	2026-01-20	2026-01-22	718	$26.96	$19.4K	23,877	SEC↗
Heyman Richard A.	Director	S Sale	2026-01-20	2026-01-22	512	$26.46	$13.5K	24,595	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2026-01-20	2026-01-22	5,491	$26.37	$144.8K	759,697	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2026-01-20	2026-01-22	14,509	$26.90	$390.3K	745,188	SEC↗
Heyman Richard A.	Director	S Sale	2026-01-09	2026-01-12	4,285	$25.00	$107.1K	25,107	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2026-01-09	2026-01-12	50,000	$29.13	$1.46M	765,188	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2026-01-09	2026-01-12	41,198	$24.90	$1.03M	815,188	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2026-01-09	2026-01-13	48,057	$27.98	$1.34M	215,254	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2026-01-09	2026-01-13	243	$28.50	$6.9K	215,011	SEC↗
Heyman Richard A.	Director	S Sale	2026-01-08	2026-01-12	1,620	$25.00	$40.5K	25,545	SEC↗
Heyman Richard A.	Director	S Sale	2026-01-08	2026-01-12	8,015	$25.04	$200.7K	29,392	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2026-01-08	2026-01-12	33,802	$24.92	$842.3K	856,386	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2026-01-08	2026-01-12	7,500	$20.13	$151.0K	890,188	SEC↗
Garland J. Scott	Director	A Award deriv	2026-01-07	2026-01-09	59,372	—	$0	59,372	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-12-22	2025-12-23	13,000	—	$0	92,056	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-12-22	2025-12-23	13,000	$2.48	$32.2K	36,000	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-12-19	2025-12-23	5,000	$16.84	$84.2K	897,688	SEC↗
Kunkel Lori Anne	Director	M Exercise deriv	2025-12-17	2025-12-19	15,958	—	$0	3,741	SEC↗
Kunkel Lori Anne	Director	M Exercise	2025-12-17	2025-12-19	15,958	$1.12	$17.9K	30,712	SEC↗
Fair Richard A.	PRESIDENT AND CEO	A Award deriv	2025-12-11	2025-12-12	875,000	—	$0	875,000	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-12-08	2025-12-10	1,705	$21.78	$37.1K	263,311	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-12-08	2025-12-10	4,958	$20.76	$102.9K	265,016	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-11-19	2025-11-21	492	$23.09	$11.4K	902,688	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-11-19	2025-11-21	12,008	$22.30	$267.8K	903,180	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-11-17	2025-11-19	12,500	$21.82	$272.8K	890,392	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-11-07	2025-11-12	613	$17.94	$11.0K	269,974	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-11-07	2025-11-12	6,054	$17.35	$105.0K	270,587	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-10-20	2025-10-22	12,500	$22.08	$276.0K	915,188	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-10-17	2025-10-21	12,500	$21.33	$266.6K	902,892	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-10-07	2025-10-09	6,667	$20.10	$134.0K	276,641	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-09-29	2025-10-01	3,250	—	$0	105,056	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-09-29	2025-10-01	3,250	$2.48	$8.1K	26,250	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-09-29	2025-10-01	3,250	$20.40	$66.3K	23,000	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-09-26	2025-09-30	3,700	$20.06	$74.2K	915,392	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-09-26	2025-09-30	4,000	$20.25	$81.0K	927,688	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-09-23	2025-09-25	2,800	$20.03	$56.1K	919,092	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-09-23	2025-09-25	1,500	$20.03	$30.0K	931,688	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-09-19	2025-09-19	1,000	$20.25	$20.3K	921,892	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-09-19	2025-09-23	2,130	$20.02	$42.6K	933,188	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-09-19	2025-09-23	4,870	$19.11	$93.1K	935,318	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-09-17	2025-09-19	5,000	$19.09	$95.5K	922,892	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-09-08	2025-09-10	6,667	$20.24	$134.9K	283,308	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-08-27	2025-08-29	3,250	—	$0	108,306	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-08-27	2025-08-29	3,250	$2.48	$8.1K	26,250	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-08-27	2025-08-29	3,250	$20.63	$67.0K	23,000	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-08-21	2025-08-21	7,500	$20.01	$150.1K	940,188	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-08-20	2025-08-21	1,517	$20.00	$30.3K	927,892	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-08-19	2025-08-20	590	$20.00	$11.8K	929,409	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-08-19	2025-08-21	5,000	$19.62	$98.1K	947,688	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-08-18	2025-08-20	10,393	$20.02	$208.1K	929,999	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-08-07	2025-08-11	6,262	$18.20	$114.0K	290,380	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-08-07	2025-08-11	405	$18.93	$7.7K	289,975	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-07-28	2025-07-30	3,250	—	$0	111,556	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-07-28	2025-07-30	3,185	$20.45	$65.1K	23,065	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-07-28	2025-07-30	65	$21.30	$1.4K	23,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-07-28	2025-07-30	3,250	$2.48	$8.1K	26,250	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-07-21	2025-07-23	576	$22.90	$13.2K	952,688	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-07-21	2025-07-23	11,924	$22.26	$265.4K	953,264	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-07-17	2025-07-21	3,663	$23.37	$85.6K	940,392	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-07-17	2025-07-21	4,687	$22.69	$106.3K	944,055	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-07-17	2025-07-21	4,150	$21.58	$89.6K	948,742	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-07-10	2025-07-14	1,000	—	$0	114,806	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-07-10	2025-07-14	1,000	$22.66	$22.7K	23,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-07-10	2025-07-14	1,000	$2.48	$2.5K	24,000	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-07-07	2025-07-09	6,362	$19.75	$125.6K	296,947	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-07-07	2025-07-09	305	$20.69	$6.3K	296,642	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-06-27	2025-07-01	3,250	—	$0	115,806	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-06-27	2025-07-01	198	$21.66	$4.3K	23,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-06-27	2025-07-01	3,052	$20.86	$63.7K	23,198	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-06-27	2025-07-01	3,250	$2.48	$8.1K	26,250	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-06-20	2025-06-24	12,500	$21.40	$267.5K	965,188	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-06-17	2025-06-18	1,998	$22.75	$45.5K	952,892	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-06-17	2025-06-18	10,502	$22.08	$231.9K	954,890	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-06-13	2025-06-17	3,000	—	$0	119,056	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-06-13	2025-06-17	3,000	$2.48	$7.4K	26,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-06-13	2025-06-17	3,000	$22.55	$67.7K	23,000	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-06-09	2025-06-11	6,607	$20.33	$134.3K	303,369	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-06-09	2025-06-11	60	$21.16	$1.3K	303,309	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-06-03	2025-06-05	7,500	$20.05	$150.4K	965,392	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-06-03	2025-06-05	7,500	$20.03	$150.2K	977,688	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-05-27	2025-05-29	3,250	—	$0	122,056	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-05-27	2025-05-29	3,250	$16.18	$52.6K	23,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-05-27	2025-05-29	3,250	$2.48	$8.1K	26,250	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-05-19	2025-05-21	5,000	$16.49	$82.4K	972,892	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-05-19	2025-05-21	5,000	$16.31	$81.5K	985,188	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-05-07	2025-05-09	6,173	$18.30	$113.0K	310,470	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-05-07	2025-05-09	104	$19.87	$2.1K	309,976	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-05-07	2025-05-09	390	$19.40	$7.6K	310,080	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-05-02	2025-05-05	2,170	$20.00	$43.4K	977,892	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-05-02	2025-05-05	2,470	$20.01	$49.4K	990,188	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-05-01	2025-05-05	5,330	$20.08	$107.0K	980,062	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-05-01	2025-05-05	5,030	$20.07	$101.0K	992,658	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-04-28	2025-04-30	3,250	—	$0	125,306	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-04-28	2025-04-30	69	$19.12	$1.3K	23,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-04-28	2025-04-30	3,181	$18.68	$59.4K	23,069	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-04-28	2025-04-30	3,250	$2.48	$8.1K	26,250	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-04-21	2025-04-23	4,670	$16.03	$74.9K	998,018	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-04-21	2025-04-23	330	$16.72	$5.5K	997,688	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-04-17	2025-04-21	5,000	$16.42	$82.1K	985,392	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-04-07	2025-04-09	2,763	$18.29	$50.5K	316,791	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-04-07	2025-04-09	148	$19.27	$2.9K	316,643	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-04-07	2025-04-09	3,756	$17.81	$66.9K	319,554	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-03-27	2025-03-31	3,250	—	$0	128,556	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-03-27	2025-03-31	3,250	$2.48	$8.1K	26,250	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-03-27	2025-03-31	3,250	$21.33	$69.3K	23,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-03-24	2025-03-26	1,000	—	$0	131,806	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-03-24	2025-03-26	1,000	$22.50	$22.5K	23,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-03-24	2025-03-26	1,000	$2.48	$2.5K	24,000	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	S Sale	2025-03-19	2025-03-21	12,500	$20.61	$257.6K	1,002,688	SEC↗
Kintz Samuel	PRESIDENT AND CEO	S Sale	2025-03-17	2025-03-19	12,500	$20.83	$260.4K	990,392	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-03-07	2025-03-11	6,667	$21.44	$142.9K	323,310	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-03-04	2025-03-06	10,000	—	$0	132,806	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-03-04	2025-03-06	10,000	$2.48	$24.8K	23,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-02-27	2025-03-03	3,250	—	$0	142,806	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-02-27	2025-03-03	3,250	$2.48	$8.1K	16,250	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-02-27	2025-03-03	3,250	$20.41	$66.3K	13,000	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-02-07	2025-02-10	6,667	$21.93	$146.2K	329,977	SEC↗
Collins Helen Louise	CHIEF MEDICAL OFFICER	A Award deriv	2025-02-06	2025-02-10	171,000	—	$0	171,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	A Award deriv	2025-02-06	2025-02-10	171,000	—	$0	171,000	SEC↗
Kintz Samuel	PRESIDENT AND CEO	A Award deriv	2025-02-06	2025-02-10	490,000	—	$0	490,000	SEC↗
Lyssikatos Joseph P	CHIEF SCIENTIFIC OFFICER	A Award deriv	2025-02-06	2025-02-10	171,000	—	$0	171,000	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	A Award deriv	2025-02-06	2025-02-10	171,000	—	$0	171,000	SEC↗
Ballal Rahul D.	Director	A Award deriv	2025-02-06	2025-02-10	20,491	—	$0	20,491	SEC↗
Bauer Jake	Director	A Award deriv	2025-02-06	2025-02-10	20,491	—	$0	20,491	SEC↗
Derynck Mika K	Director	A Award deriv	2025-02-06	2025-02-10	20,491	—	$0	20,491	SEC↗
Gupta Rishi	Director, 10% Owner	A Award deriv	2025-02-06	2025-02-10	20,491	—	$0	20,491	SEC↗
Heyman Richard A.	Director	A Award deriv	2025-02-06	2025-02-10	23,014	—	$0	23,014	SEC↗
Kunkel Lori Anne	Director	A Award deriv	2025-02-06	2025-02-10	15,368	—	$0	15,368	SEC↗
Phillips Andrew John	Director	A Award deriv	2025-02-06	2025-02-10	20,491	—	$0	20,491	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-02-05	2025-02-07	1,000	—	$0	146,056	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-02-05	2025-02-07	1,000	$22.52	$22.5K	13,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-02-05	2025-02-07	1,000	$2.48	$2.5K	14,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-01-27	2025-01-29	3,250	—	$0	147,056	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-01-27	2025-01-29	3,250	$2.48	$8.1K	16,250	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-01-27	2025-01-29	3,250	$21.59	$70.2K	13,000	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	M Exercise deriv	2025-01-07	2025-01-10	10,700	—	$0	67	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	M Exercise deriv	2025-01-07	2025-01-10	2,000	—	$0	827	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	M Exercise deriv	2025-01-07	2025-01-10	9,000	—	$0	44,342	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-01-07	2025-01-10	90	$24.60	$2.2K	336,644	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-01-07	2025-01-10	6,577	$24.17	$159.0K	336,734	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-01-07	2025-01-10	1,440	$24.56	$35.4K	0	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	S Sale	2025-01-07	2025-01-10	20,260	$24.15	$489.3K	1,440	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	M Exercise	2025-01-07	2025-01-10	9,000	$2.48	$22.3K	21,700	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	M Exercise	2025-01-07	2025-01-10	2,000	$2.48	$5.0K	12,700	SEC↗
Patel Anish	CHIEF OPERATING OFFICER	M Exercise	2025-01-07	2025-01-10	10,700	$1.12	$12.0K	10,700	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-01-03	2025-01-07	1,000	—	$0	150,306	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2025-01-03	2025-01-07	1,000	$2.48	$2.5K	14,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2025-01-03	2025-01-07	1,000	$25.04	$25.0K	13,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2024-12-30	2024-12-31	900	—	$0	164,306	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2024-12-30	2024-12-31	900	$2.48	$2.2K	900	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2024-12-30	2024-12-31	900	$22.51	$20.3K	0	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2024-12-27	2024-12-31	3,350	—	$0	165,206	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2024-12-27	2024-12-31	3,350	$22.15	$74.2K	0	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2024-12-27	2024-12-31	3,350	$2.48	$8.3K	3,350	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2024-12-13	2025-01-07	13,000	—	$0	155,556	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2024-12-13	2025-01-07	13,000	$2.48	$32.2K	13,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2024-11-27	2024-12-02	5,250	—	$0	168,556	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2024-11-27	2024-12-02	1,000	$25.38	$25.4K	0	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	S Sale	2024-11-27	2024-12-02	4,250	$24.78	$105.3K	1,000	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise	2024-11-27	2024-12-02	5,250	$2.48	$13.0K	5,250	SEC↗
Hohl Benjamin	CHIEF FINANCIAL OFFICER	M Exercise deriv	2024-10-28	2024-10-30	6,250	—	$0	173,806	SEC↗